शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
ARTEMISMEDBSEARTEMIS MED SERVICE LTD· Healthcare ServicesHighNeutral
Announced Mon, 3 Aug, 2026 · 17:28 IST

Artemis Medicare Q1 FY27 PAT jumps 45% YoY on revenue growth

Profit growth above 25%EBITDA margin expansionResults View source PDFExplain this filing

ARTEMISMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.7%Reaction day
₹303.30
prior close
₹305.00
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-1.2% vs market
Hospital peers, median of 26sector+0.3%-1.1% vs sector

On the reaction day the stock moved 1.2 pts less than Nifty Microcap 250 and 1.1 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.1
10m
-1.1
15m
-0.9
30m
-0.6
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.7+0.4-1.2+0.3-1.1
Next day
+5.6+1.7+3.9+0.0+5.6
2d
+2.4+2.1+0.3+0.2+2.2
3d
+4.7+2.1+2.6+1.2+3.5
4d
+4.3+2.1+2.2+1.0+3.3
5d
+3.4+1.9+1.5-0.7+4.1
1w
+4.5+2.4+2.1-2.2+6.7
15d
+7.1+3.0+4.0-1.5+8.6
1m
+9.8+3.7+6.0-2.9+12.7
2m
+7.1+1.6+5.6-9.2+16.4
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 26Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Q1 FY27 standalone revenue rose to Rs 28,201 lakhs (up about 13% from Rs 24,980 YoY). PAT jumped 45% to Rs 3,105 lakhs from Rs 2,142 lakhs. Consolidated PAT was Rs 3,144 lakhs, up about 48%. EBITDA margin expanded to roughly 21.6% from 19.1%. Auditor issued unmodified conclusion. Board also approved Tower IV expansion at Gurugram hospital, adding 200 plus beds at Rs 160 to 180 crore via internal accruals and debt.

Likely market impact

Strong earnings signal solid hospital demand. Tower IV expansion adds growth runway, debt-funded Rs 160 to 180 crore capex may pressure margins short term.